IMA Clinical Research — New York, New York

IMA Clinical Research is a clinical research site located in New York, New York, United States 10128.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

IMA Clinical Research has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Major Depressive Disorder, Alzheimer Disease, Diabetic Peripheral Neuropathic Pain.

Sponsors: Xenon Pharmaceuticals Inc., Eli Lilly and Company, Eliem Therapeutics (UK) Ltd..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for IMA Clinical Research?

IMA Clinical Research has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has IMA Clinical Research conducted?

IMA Clinical Research has 7 clinical trials on record, with 3 currently active. Their work covers Major Depressive Disorder, Alzheimer Disease, Diabetic Peripheral Neuropathic Pain.

Is IMA Clinical Research accredited by Crixeo Health?

Yes — IMA Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about IMA Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.